In their last 10-Q received on 11/13/2020, Lifeloc stated they believe they should be able to introduce the marijuana breathalyzer by the end of 2021 - as an excerpt from this filing states below.
In August 2016, we entered into an exclusive patent license agreement with Sandia Corporation, Albuquerque, NM, pursuant to which we acquired the exclusive rights to develop, manufacture and market Sandia's patented SpinDx™ technology for the detection of drugs of abuse. SpinDx™ uses a centrifugal disk with micro fluidic flow paths allowing multiple tests to be carried out on a single small sample. Sandia Corporation developed a prototype using the SpinDx™ technology under our Cooperative Research and Development Agreement. We received the prototype in 2018 and are now commercializing the device. The SpinDx™ platform has the potential to improve real-time screening for a panel of high-abuse drugs, with the ability to efficiently and quantitatively measure relatively low concentrations of drugs such as cocaine, heroin, methamphetamine, fentanyl and other high-abuse drugs. We intend to use this technology, sometimes referred to as "Lab on a Disk", to develop devices and tests that could be used at roadside, emergency rooms and in workplace testing to get a rapid and quantitative measure for a panel of such drugs of abuse. We have detected delta-9-THC (the primary psychoactive component of marijuana) down to concentrations of 5 nanograms per milliliter in our laboratory. This includes resolving the psychoactive delta-9-THC from its inactive metabolites, an important step in differentiating current impairment from historical usage. We completed the upgrade of our base breathalyzer platform in 2019 (the LX9), and we remain committed to combining it with the SpinDx™ technology. Our goal is to use this combination to develop a THC breathalyzer. Earlier this year, we added to our expertise by hiring staff who bring skills highly relevant to the development of SpinDx. We believe these advances in our team’s expertise will better equip us in our attempts to introduce this important product by the end of 2021. There is no assurance that our efforts to develop a marijuana breathalyzer will be successful or that significant sales will result from such development if successful.
Comparisons of the two companies has been largely discussed on this board in the past. Please feel free to do your own research, and do as you seem best.
Sandia National Laboratories is operated and managed by National Technology and Engineering Solutions of Sandia, LLC., a wholly owned subsidiary of Honeywell International, Inc. Honeywell is a big boy and has revenue over $36 Billion/year
Sandia National Laboratories has an annual budget of $3.6 Billion
The inventors of the SpinDx platform are licensing the technology to several companies that are developing its use for point-of-care diagnostics testing, water pathogen testing, and other applications.
This is where Lifeloc comes in. They are using the SpinDx platform, in combination with the LX9 base breathalyzer platform to create a device for drug detection.
4 years ago Lifeloc acquired the exclusive rights to develop, manufacture and market Sandia's patented SpinDx™ technology for the detection of drugs of abuse.
They received the prototype almost 3 years ago and have been working to commercialize the device.
They have detected delta-9-THC (the primary psychoactive component of marijuana) down to concentrations of 5 nanograms per milliliter in their laboratory.
Lifloc added staff in early 2020 to help with the development of the SpinDx platform.
They are attempting to introduce the marijuana breathalyzer and drug detection device by the end of this year.
News 
Market Data 
Discover 
